Strides Pharma Science (STAR.NS) Stock Price
Strides Pharma Science Price
Over the last 20 years Strides Pharma Science grew revenue by 11.4% annually, reaching 45.65 B INR. Earnings per share have grown at 19.0% per year over the last 20 years. For Strides Pharma Science, the net margin of 78.7% is up versus 8.1% a few years ago. At today's price the dividend yield works out to roughly 0.40%. The payout ratio is around 1% of earnings. The dividend has grown at 5.0% per year over the past 20 years. The consensus 12-month price target for Strides Pharma Science is 1,252.56 INR, about 25.5% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Strides Pharma Science stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Strides Pharma Science business model & stock analysis
Frequently asked questions about Strides Pharma Science
Analysts currently set an average price target of 1,252.56 INR for the Strides Pharma Science stock (median: 1,252.56 INR), implying +25.5 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Strides Pharma Science stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Strides Pharma Science to generate revenue of 48.28 B INR and earnings per share of 58.89 INR.
Converted at the current exchange rate, the Strides Pharma Science share trades at 9.41 EUR (998.40 INR).
The Strides Pharma Science share (STAR.NS) is listed on 2 stock exchanges, including: NSE (Indien) (STAR.NS).
The expected revenue of Strides Pharma Science is 48.28 B INR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Strides Pharma Science is 5.42 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Strides Pharma Science is currently 16.95. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Strides Pharma Science stock.
The price-to-sales ratio (P/S) of Strides Pharma Science is currently 1.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Strides Pharma Science stock.
The Eulerpool Quality Score for Strides Pharma Science is 6/10.
The ISIN of Strides Pharma Science is INE939A01011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Strides Pharma Science is STAR.NS. The ticker symbol is used to trade Strides Pharma Science shares on the stock exchange.
Strides Pharma Science stock
Strides Pharma Science Peer Group
Strides Pharma Science Ticker
Strides Pharma Science FIGI
All fundamentals and in-depth analysis of Strides Pharma Science
Our stock analysis for Strides Pharma Science stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Strides Pharma Science. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.